JP Morgan Call 160 AKAM 17.01.202.../ DE000JK072L4 /
13.05.2024 12:47:05 | Изменение-0.013 | Бид13:00:10 | Предложение13:00:10 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.061EUR | -17.57% | 0.061 Величина цены спроса: 2,000 |
0.160 Величина цены предложения: 2,000 |
Akamai Technologies ... | 160.00 USD | 17.01.2025 | Call |
GlobeNewswire
13:15
Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and C...
Newsfile Corp
13:15
Perseverance Metals Strengthens Its Board of Directors, Management and Advisory Teams with the Addit...
GlobeNewswire
13:15
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fis...
GlobeNewswire
13:07
EnviroGold Global Announces the Appointment of Paul McRae as an Independent Director
GlobeNewswire
13:00
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Tr...
GlobeNewswire
13:00
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
GlobeNewswire
13:00
Bitfarms Announces Acceleration of Previously Announced Termination of CEO and Provides Update on Ne...
GlobeNewswire
13:00
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
GlobeNewswire
13:00
Lilium in advanced discussions with French government to expand industrial footprint with high-volum...
GlobeNewswire
13:00
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница